Morphometric imaging biomarker identifies Alzheimer’s disease even among mixed dementia patients

A definitive diagnosis of Alzheimer’s disease (AD), even in the presence of co-morbid neuropathology (occurring in > 50% of AD cases), is a significant unmet medical need that has obstructed the discovery of effective AD therapeutics. An AD-biomarker, the Morphometric Imaging (MI) assay on cultur...

Descripción completa

Detalles Bibliográficos
Autores principales: Chirila, Florin V., Xu, Guang, Fontaine, Dan, Kern, Grant, Khan, Tapan K., Brandt, Jason, Konishi, Yoshihiro, Nebe-von-Caron, Gerhard, White, Charles L., Alkon, Daniel L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9626495/
https://www.ncbi.nlm.nih.gov/pubmed/36319674
http://dx.doi.org/10.1038/s41598-022-21796-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9626495/
https://www.ncbi.nlm.nih.gov/pubmed/36319674
http://dx.doi.org/10.1038/s41598-022-21796-y

Ejemplares similares